Profile
Daniel J.
Burge worked as a Vice President of Clinical Research & Development at Amgen, Inc. and Immunex Corp.
from 2000 to 2003.
He then worked as the Chief Medical Officer & Senior Vice President at Emergent Product Development Seattle from 2004 to 2008.
After that, he held the position of Senior Vice President of Clinical Development at Dermira, Inc. and Chief Medical Officer & Head of Clinical Development at Forte Biosciences, Inc. Dr. Burge holds a doctorate degree from Thomas Jefferson University and an undergraduate degree from Taylor University.
Former positions of Daniel J. Burge
| Companies | Position | End |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 2008-08-28 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Chief Tech/Sci/R&D Officer | 2001-12-31 |
| DERMIRA, INC. | Chief Tech/Sci/R&D Officer | - |
| FORTE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Daniel J. Burge
| Thomas Jefferson University | Doctorate Degree |
| Taylor University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| FORTE BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- Daniel J. Burge
